5th Extrahepatic Lipid-Based Nanoparticles Delivery Summit 2026

 

The 5th Extrahepatic Lipid-Based Nanoparticles Delivery Summit returns to Boston in June 2026 as the leading event focused on advancing extrahepatic LNP delivery and targeted lipid nanoparticle technologies.

Bringing together 60+ experts from biopharma and academia, this three-day summit will explore novel targeting ligands, formulation strategies, and scalable manufacturing approaches to enable precise, tissue-specific delivery beyond the liver.

With growing industry momentum, including strategic investments from AbbVie and Bristol Myers Squibb, discussions will accelerate mRNA, RNA, gene-editing, and cell therapy delivery to immune cells, muscle, and adipose tissue. Gain insights into LNP analytics, immunogenicity, and clinical translation.

More Info

---

---